|
Juan Sanabria, MD, MSc, FRCSC, FACS, Joins Cancer Treatment Centers of …
PR Newswire (press release) … St Michael’s Hospital. Dr. Sanabria also completed a fellowship in the Epidemiology Unit G.I. Cancer Registry at Mount Sinai Hospital, as well as a fellowship in the HPB and Transplant Surgery Multi-Organ Transplant Unit at the University of Toronto. |
|
On Brain Death and Civil Rights
Justia Verdict Ventilator The unfortunate situation of Jahi McMath, the 13-year-old girl who was pronounced brain dead a few days after a tonsillectomy surgery at Children’s Hospital Oakland last month, has captured national attention after the girl’s family refused … |
The Yucatan Times |
Yucatan in the top ten of organ donation
The Yucatan Times “The culture of organ donation in Yucatan grows slowly to the awareness of people about the importance of donating their tissues at death, which has been favored since 1987 when the first surgery was performed, about 400 transplants have been made … |
PA home pageMusto in court for competency hearingWilkes Barre Times-LeaderDr. Cataldo Doria, chief of transplant surgery at Thomas Jefferson Hospital in Philadelphia, testified via video conference saying Musto suffers non-alcoholic cirrhosis of the li…
Drug Discovery & Development |
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from …
MarketWatch … showing PIXUVRI’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving PIXUVRI as a third- or fourth-line … UK’s NICE Issues Final Appraisal Determination on CTI Lymphoma DrugDrug Discovery & Development Cell Therapeutics Inc (CTIC): Is Cell Therapeutics Turning Over A New Leaf In …Seeking Alpha |
Restoring the Hair of our HeroesHuffington PostHair transplant surgery has come a long way since the days of plugs. I initially entered the field of hair restoration after seeing how great my father looked after his hair transplant about 10 years ago. …
Cell Therapeutics Inc (CTIC): Is Cell Therapeutics Turning Over A New Leaf In …Seeking AlphaThe company is currently accruing patients into this study, which will compare Pixantrone and rituximab with gemcitabine and rituximab in the setting of aggre…
|
Family of brain-dead Jahi McMath has ‘real concerns’ about safety
Los Angeles Times Jahi suffered heavy bleeding, cardiac arrest and “whole brain death” — defined as an irreversible cessation of all functions of the entire brain, including the brain stem — on Dec. 12, three days after complex tonsillectomy surgery. Two hospital … |
University of Delaware |
Study to address exercise and vascular function in chronic kidney disease
University of Delaware 11:05 a.m., Jan. 6, 2014–Chronic kidney disease, which affects more than 20 million adults in the United States, carries with it a high risk of cardiovascular disease. In fact, even a small loss of kidney function can double a person’s risk of … |
Drug Discovery & Development |
UK’s NICE Issues Final Appraisal Determination on CTI Lymphoma Drug
Drug Discovery & Development … reviewed CTI’s updated data analysis showing Pixuvri’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving … PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from …MarketWatch |